Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Needham

Omada Health Analysts Say 'Buy' — While It's Still Below IPO Price

Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating.

Benzinga

Crexendo's Open Strategy Pays Off, Analyst Praises 'Disruptive Pricing Model'

Crexendo Inc (NASDAQ:CXDO) appears poised to gain share in the wholesale UCaaS (United Communications as a Service) market, according to Needham.

Benzinga

Dayforce: Native Platform To Drive Deal Growth, Says Bullish Analyst

Dayforce Inc (NYSE:DAY) offers a natively built platform that could drive more deals through human capital management partners, a Needham analyst says.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Tesla To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Hims Stock Tumbles Down After Abrupt Exit of Novo Nordisk: Here's Everything That Went Wrong

Novo Nordisk alleged that some telehealth entities, including Hims & Hers, used illicit semaglutide sourced from unregulated Chinese manufacturers not approved or inspected by the FDA.

International Business Times UK

Analysts: 1 Thing Apple Could Do to Make AAPL Stock a Buy Again Now

A rare downgrade from Needham urges Apple to tap into advertising as a new growth engine amid slowing earnings, rising competition, and valuation concerns.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Apple Just Got a Rare Downgrade. Should You Ditch AAPL Stock Now?

Apple's slowing growth, rising tariffs, and AI lag could crack its trillion-dollar armor.

Barchart

Navitas Semiconductor Just Landed a Nvidia Deal. How Should You Play NVTS Stock Here?

Navitas stock skyrockets after the power semiconductor firm announced a partnership with Nvidia. Needham analysts warn the NVTS rally may have gone a bit too far.

Barchart

Should You Buy the Post-Earnings Dip in SMCI Stock?

Supermicro stock is sinking as the AI server specialist lowers guidance for the full year again. Needham analysts continue to see significant upside in SMCI shares.

Barchart

This ‘Strong Buy’ AI Stock Offers ‘Sweeping Innovation.’ Analysts Say It Also Offers $100 Per Share in Upside Potential.

Despite the market’s choppy ride this year, Needham analysts foresee huge potential in this ‘Strong Buy’-rated AI stock.

Barchart

Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?

Analyst firm Needham reaffirms its confidence in Archer Aviation, highlighting operational progress and the stock's upside potential.

MarketBeat

Analysts Are Calling for Apple’s 2025 EPS to Fall 28%. Should You Buy, Sell, or Hold AAPL Stock Here?

Apple is under pressure as tariffs and a bleak earnings outlook shake investor confidence, leaving the future of AAPL stock in question.

Barchart

This Nvidia-Backed AI Stock Is Shrugging Off Market Pain Thanks to the FDA. Should You Buy Shares Now?

Recursion Pharmaceuticals stock rallied as FDA announces plans of using AI for drug testing. Is it too late to invest in RXRX shares?

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Needham Is Doubling Down on D-Wave Quantum Stock. Is It Time to Buy?

D-Wave recently reported its results for Q4.

Barchart

Dear Rigetti Stock Fans, Mark Your Calendars for March 12

Investors expect key insights from Rigetti’s CEO at the Cantor Technology Conference on March 12, focusing on future developments.

Kiplinger

eBay Stock Slides on Soft Outlook

eBay stock is falling Thursday after the e-commerce company topped fourth-quarter expectations but issued a soft first-quarter outlook.

Barchart

An Analyst Just Tripled His Price Target on This Quantum Computing Stock

An analyst just tripled his price target on IonQ as quantum computing momentum surges.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is SoFi Stock a Buy, Sell, or Hold for 2025?

SoFi crushed expectations in 2024, but weak 2025 guidance triggered a selloff. Should investors buy the dip, hold, or cash out?

Kiplinger

Tesla Stock Rallies Despite Earnings Miss

Tesla stock is moving higher despite coming up short of expectations for its fourth quarter. Here's what you need to know.

Kiplinger

Taiwan Semiconductor Earnings Fuel a Rally in Chip Stocks

Taiwan Semiconductor stock is higher Thursday after the chip manufacturer beat expectations for its fourth quarter and issued a strong outlook. Here's what you need to know.

Kiplinger

Why MongoDB Stock Is Down After Its Beat-And-Raise Quarter

MongoDB stock is spiraling Tuesday even after the tech company disclosed higher-than-expected Q3 earnings and raised its full-year outlook. Here's why.

Benzinga

Coinbase Seeing 'Landmark Month' In December, Notes Optimistic Analyst Report

Needham & Company has raised Coinbase‘s (NASDAQ:COIN) price target to $420 from $375, citing record-breaking December trading volumes and heightened altcoin activity.

Benzinga

Tesla To $370? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Smart Money Is Betting Big In COIN Options

Deep-pocketed investors have adopted a bullish approach towards Coinbase Glb (NASDAQ:COIN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COIN usually suggests something big is…

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.